COVID-19 infection in children with acute lymphoblastic leukemia in China: Mild clinical course after Omicron infection

Jiaoyang Cai,Chikong Li,on behalf of the CCCG ALL Study Group
DOI: https://doi.org/10.1097/cm9.0000000000003183
IF: 6.133
2024-08-21
Chinese Medical Journal
Abstract:To the Editor: Since December 2019, the coronavirus pandemic has been the deadliest disaster with over 6.5 million people confirmed to have died in less than 3 years. [ 1 ] The coronavirus disease 2019 (COVID-19) has created the biggest global crisis in generations. Children are less likely to develop severe illness than adults, but children with cancer are more likely to develop a serious clinical course and even die after the infection. [ 2,3 ] Since early 2022, the Omicron variant has become the main variant of SARS-CoV-2 across the globe. In the first three years of the pandemic when China has taken very strict infection control measures, the number of reported cases of COVID-19 infection in China was low and children with cancer were rarely affected by the COVID-19 infection. Since early December 2022, China has changed the infection control policy for COVID-19 and allowed more flexible approaches to patients infected with COVID-19. The number of infected cases increased rapidly in the subsequent two months and reached the peak of more than 40 million per week in mid-December 2022. [ 4 ] Although vaccination rate against COVID-19 was high in China in general, the Omicron variant has very high infection rate and vaccination may only protect patients from serious illnesses.
medicine, general & internal
What problem does this paper attempt to address?